William Wind, MD
Orthopaedic Surgery · Amherst, NYNPI 1932179736
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $88,085 of the $109,444 with a category attached, or 80.5%. Arthrex accounts for 87.7% of it on its own, with 18 other manufacturers making up the rest. 2025 is the largest year on record at $39,427, 3.3 times the $11,987 reported in 2019.
Across 228 payments — averaging $480.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$96K
- Smith+Nephew$7K
- Prodigy Surgical Distribution, Inc.$6K
- Stryker$345
- Ferring Pharmaceuticals Inc.$215
- Pacira Therapeutics, Inc.$131
- plus $463 from 13 others
Across 4 payments — averaging $13,614 each. An ownership or investment interest held by the physician or an immediate family member.
- Lazurite Inc.$54K
What the payments were for
- Speaking & faculty fees$88,08580%
- Travel & lodging$11,46410%
- Food & beverage$8,0007%
- Education$1,8952%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 108 | $96,011 |
| Smith+Nephew | 56 | $6,724 |
| Prodigy Surgical Distribution, Inc. | 24 | $5,555 |
| Stryker | 7 | $345 |
| Ferring Pharmaceuticals Inc. | 11 | $215 |
| Pacira Therapeutics, Inc. | 6 | $131 |
| FX Shoulder Solutions, Inc | 1 | $125 |
| Bioventus LLC | 3 | $79 |
| Lifenet Health | 1 | $61 |
| Axogen | 1 | $49 |
| Avanos Medical | 2 | $32 |
| Johnson & Johnson | 1 | $24 |
| Dynasplint Systems Inc. | 1 | $17 |
| Orthofix Medical, Inc. | 1 | $15 |
| KCI USA, Inc. | 1 | $14 |
| Amgen | 1 | $14 |
| DJO, LLC | 1 | $12 |
| Pacira Pharmaceuticals Incorporated | 1 | $12 |
| Heraeus Medical, LLC. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Healicoil$2,035
- Bone Anchors with Arthroscopic Delivery System$854
- SPATIAL FRAME$813
- Regeneten$732
- NOVOSTITCH$731
- Bioinductive Implant with Arthroscopic Delivery System - Medium$674
- Journey II XR$643
- Endobutton$605
- Q-FIX$533
- HEALICOIL REGENESORB$415
- Fast-Fix 360$290
- Accu-pass$273
- Firstpass$268
- MICRORAPTOR$245
- REGENETEN Shoulder$147
- Biosure$145
- LENS Surgical Imaging System$145
- MULTIFIX S$145
- LENS 4K$143
- Q-FIX Shoulder$126
How this compares
$109,444 in reported general payments places this provider in the 85th percentile of 1,079 orthopaedic surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 25 | $91 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Amherst
- Anthony RomeoNew York$26.8M
- Lawrence LenkeNew York$26.8M
- Edwin SuNew York$13.2M
- William RicciNew York$11.6M
- Steven HaasNew York$11.3M
- Giles ScuderiNew York$10.7M
- Joseph ZuckermanNew York$9.9M
- Evan FlatowNew York$9.6M
- Bradford ParsonsNew York$9.4M
- Geoffrey WestrichNew York$7.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.